Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”
This article is from
The Cancer Letter
archive.
Vol. 02 No. 04 | January 23, 1976
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
FDA Ceases Exclusion Of Women From Early Drug Studies
May 7, 1993
TCL Archive
Possible Breach of Patient Confidentially By Calif. Physician; NCI
May 6, 1994
TCL Archive
Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?
April 16, 1999
TCL Archive
Trapido To Lead NCI’s Epidemiology Program.
July 26, 2002
TCL Archive
NIH Reauthorization Threatened By Fetal Research Issue
October 5, 1990
TCL Archive
About Need For Cancer Research Funding
February 3, 1995